Tag: Biotech Deal
Skadden advises Otsuka on potential USD1.2bn biotech buy
Skadden, Arps, Slate, Meagher & Flom is advising Tokyo-based Otsuka Pharmaceutical on its acquisition of clinical-stage biotechnology company
Skadden, Arps, Slate, Meagher & Flom is advising Tokyo-based Otsuka Pharmaceutical on its acquisition of clinical-stage biotechnology company
Corporate governance is evolving beyond compliance to encompass accountability, sustainability?and long-term value
Follow us on LinkedIn